Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 25/07/2011 14835_de.jpg

    Cell culture technology: hamster cells and the production of biopharmaceuticals

    Biopharmaceuticals are one of the best selling drugs. The majority of successful biopharmaceutical ingredients are produced in CHO cell lines. Strong competition forces biopharmaceutical producers to continuously improve the drug development process and the production methods, which requires highly qualified experts.

    https://www.gesundheitsindustrie-bw.de/en/article/news/cell-culture-technology-hamster-cells-and-the-production-of-biopharmaceuticals
  • Article - 25/07/2011 The photo shows the face of a dark-haired man with glasses.

    Christian Thoma – the control of translation enables the rapid regulation of cellular processes

    Heisenberg fellow PD Dr. Christian Thoma from the Freiburg University Medical Centre has been focusing on the regulation of translation for a number of years and has established a method that enables him to investigate translation on the molecular level. Thoma and his team have come a step closer to their goal of finding targets for the therapy of cancer and hepatitis C.

    https://www.gesundheitsindustrie-bw.de/en/article/news/christian-thoma-the-control-of-translation-enables-the-rapid-regulation-of-cellular-processes
  • Article - 25/07/2011 14863_de.jpg

    Cell culturing as a taught subject: many more “Biberachs” are needed

    Cell culture technology is only taught at a handful of universities. However, this interdisciplinary subject is the core of the “Pharmaceutical Biotechnology” programme offered by the Biberach University of Applied Sciences. We talked about the subject with Professor Jürgen Hannemann, founding dean of the “Pharmaceutical Biotechnology” programme, and with Professor Friedemann Hesse, who runs the “cell culture technology” teaching programme.

    https://www.gesundheitsindustrie-bw.de/en/article/news/cell-culturing-as-a-taught-subject-many-more-biberachs-are-needed
  • Article - 25/07/2011 14841_de.jpg

    Silke Brüderlein has “green fingers” for cell cultures

    Many researchers in the biosciences work with cell cultures, but not all of them seem to understand them at a deeper level. The biologist Silke Brüderlein from the Institute of Pathology in Ulm is a specialist in cell culture and is well aware of the problems that might arise when working with cell cultures.

    https://www.gesundheitsindustrie-bw.de/en/article/news/silke-bruederlein-has-green-fingers-for-cell-cultures
  • Dossier - 25/07/2011 Biberach-based Boehringer Ingelheim produces biopharmaceuticals on the basis of cell cultures. Here, the inoculation of cell cultures is shown. This is the first step in industrial-scale cell culture.

    Cell culture technology: it all started with frog nerve fibres

    The history of cell culture technology is closely connected with cell biology and the discoveries made in the field of cell biology. Ever since the study of science became a professional activity, researchers have been trying to keep cells and tissues alive outside organisms for purposes of investigation.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/cell-culture-technology-it-all-started-with-frog-nerve-fibres
  • Article - 25/07/2011 14847_de.jpg

    The mixture is key: what cells like to feed on

    Dr. Aziz Cayli knows CHO (Chinese hamster ovary) cells so well that he decided to establish his own company in 2005. Prior to establishing CellCa GmbH in the city of Laupheim, Cayli held posts at Roche in Penzberg and Boehringer Ingelheim in Biberach. CellCa is a specialist in upstream processing and with its current total of 15 staff, the company achieved revenues of around two million euros in 2009. We talked with Dr. Aziz Cayli who did his…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-mixture-is-key-what-cells-like-to-feed-on
  • Press release - 23/07/2011

    Innovative strength in Baden-Württemberg

    The Baden-Württemberg Ministry of Finance and Economics presented the results of two studies that evaluated the innovative strength of Baden-Württemberg in comparison to other regions around the world. The studies were carried out by the University of Hohenheim and the independent research institute BAK Basel Economics AG BAK Basel on behalf of the Baden-Württemberg Ministry of Finance and Economics and they were financed by the Baden-Württemberg…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/innovative-strength-in-baden-wuerttemberg
  • Press release - 21/07/2011 Phenex Logo

    Phenex wins the former Head of Diabetes and Metabolic Diseases at Sanofi Aventis as advisor

    Phenex Pharmaceuticals AG today announced the engagement of Prof. Dr. Dr. Werner Kramer, the former Head of Diabetes and Metabolic Diseases R&D at Sanofi Aventis, as a senior scientific advisor. At the end of last year, Prof. Kramer has left Sanofi Aventis after 25 years of very successful practice in drug discovery and development to devote himself to new scientific challenges. His long- and outstanding expertise in research and development…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/phenex-wins-the-former-head-of-diabetes-and-metabolic-diseases-at-sanofi-aventis-as-advisor
  • Press release - 20/07/2011 12118_de.jpg

    Roche acquires mtm laboratories AG, expanding offering in cervical cancer

    Roche announced on July 19th that it has signed an agreement under which it will acquire 100 percent of mtm laboratories AG (mtm), a privately-held company based in Heidelberg, Germany. mtm is a global leader in developing in vitro diagnostics with a focus on early detection and diagnosis of cervical cancer, the largest early detection market in oncology. mtm will become part of Roche’s Tissue Diagnostics (Ventana Medical Systems, Inc.) business…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/roche-acquires-mtm-laboratories-ag-expanding-offering-in-cervical-cancer
  • Article - 18/07/2011 The photo shows an X-ray image of a jaw from the front; numerous screws with artificial teeth attached to them are shown in white.<br />

    Titanium screws and stem cells for dental implants

    How are we supposed to chew and smile when the tooth fairy comes to fetch our second set of teeth? When it’s difficult to tell the difference between modern tooth implants and real teeth in both technical and aesthetical terms, people who lose their teeth due to accidents or age very quickly regain their smile. However, there needs to be enough bone to hold and support the implant. Prof. Dr. Dr. Ralf Gutwald and his team in the Department of Oral…

    https://www.gesundheitsindustrie-bw.de/en/article/news/titanium-screws-and-stem-cells-for-dental-implants
  • Article - 18/07/2011 14777_de.jpg

    JRS – creating sustainability with fibres

    Fibres can be used to disintegrate tablets, bind together the ingredients in a formulation and coat substrates. The company J. RETTENMAIER & SÖHNE GmbH+Co.KG has been offering plant fibres, pulp and cellulose for a broad range of applications since 1878. The company now also uses the natural fibres for the fabrication of bioplastics in an effort to contribute to sustainability.

    https://www.gesundheitsindustrie-bw.de/en/article/news/jrs-creating-sustainability-with-fibres
  • Press release - 15/07/2011 10938_de.jpg

    HITS Participates in a new DFG Research Unit on Blood Coagulation

    Scientists from the Heidelberg Institute for Theoretical Studies participate in a new Research Unit on blood coagulation sponsored by the German Research Foundation (DFG). The aim of the DFG funding is to support a successful existing cooperation between scientists over several years.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hits-participates-in-a-new-dfg-research-unit-on-blood-coagulation
  • Press release - 13/07/2011 14775_de.jpg

    Kinetochores prefer the “silent” DNA sections of the chromosome

    The centromere is a specialized region of the chromosome, on which a protein complex known as the kinetochore is assembled. During cell division, the kinetochore provides a point of attachment for molecules of the cytoskeleton, thereby mediating the segregation of chromosomes to the two opposing cell poles. Scientists from the Max Planck Institute of Immunobiology and Epigenetics and BIOSS in Freiburg have investigated the factors that play an…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/kinetochores-prefer-the-silent-dna-sections-of-the-chromosome
  • Article - 12/07/2011 15029_de.jpg

    Deeper insight into the activity of the cortex

    Visual and tactile objects in our surroundings are translated into a perception by complex interactions of neurons in the cortex. The principles underlying spatial and temporal organization of neuronal activity during decision-making and object perception are not well understood yet. Jason Kerr from Max Planck Institute for Biological Cybernetics in Tübingen, in collaboration with Winfried Denk from the Max Planck Institute for Medical Research…

    https://www.gesundheitsindustrie-bw.de/en/article/news/deeper-insight-into-the-activity-of-the-cortex
  • Press release - 12/07/2011 14753_de.jpg

    Cortisol Controls Recycling of Bile Acids

    Scientists of the German Cancer Research Center DKFZ have made a discovery in mice whose liver cells are unable to receive cortisol signals This hormone is responsible for a process in which the liver recycles bile acids from the blood. If this recycling is disrupted the animals develop gallstones and lose weight because they are no longer able to digest dietary fats.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/cortisol-controls-recycling-of-bile-acids
  • Dossier - 04/07/2011 The cement-free Metha® Short Hip Stem prosthesis with Plasmapore® µ-CaP coating of the entire proximal surface supports rapid secondary fixation. µ-CaP is applied on the microporous titanium Plasmapore® surface. It has an osteoconductive effect and accelerates contact between the bone and the prosthesis stem.

    Implants of the future: bioactive, corrosion-resistant and antibacterial

    People’s life expectancy is increasing due to constantly improving medical treatment. One result of this is the greater wear of joints, which then need to be replaced with implants. Increased life expectancy means that the implants remain in the body for much longer and therefore need to be longer lasting. The revision rate of implant materials used in clinical practice is still as much as 10 per cent, particularly in the case of hip and knee…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/implants-of-the-future-bioactive-corrosion-resistant-and-antibacterial
  • Article - 04/07/2011 The biopolymers are turned into fibres in the institute's melt spinning plant and subsequently used for the production of textiles.<br />

    Synthetic tendons made from bicomponent fibres

    Organs are not the only things to be transplanted. Sometimes tendons also need to be replaced. At St. Gallen-based Empa (Swiss Federal Laboratories for Materials Science and Technology), an interdisciplinary team of scientists is working on the development of synthetic tendons for surgical applications. The synthetic tendons are made of bicomponent fibres that decompose efficiently in the body after implantation.

    https://www.gesundheitsindustrie-bw.de/en/article/news/synthetic-tendons-made-from-bicomponent-fibres
  • Article - 04/07/2011 14700_de.jpg

    Stefan Rensing investigates the evolutionary transition from algae to land plants

    The biologist Prof. Dr. Stefan Rensing from the University of Freiburg has been involved in introducing the use of computers to the life sciences from the very beginning. His analyses of the moss genomes now help to close an important gap in evolutionary research how did algae become land plants?

    https://www.gesundheitsindustrie-bw.de/en/article/news/stefan-rensing-investigates-the-evolutionary-transition-from-algae-to-land-plants
  • Article - 04/07/2011 The photo shows a cuboid structure with rounded edges, corrugated surface and several lateral openings.

    Orthobion GmbH: biomaterials for spinal implants

    If one takes a closer look at the mechanisms involved in bone growth, it turns out that the supposedly simple issue as to how bones grow cannot be fully answered. Konstanz-based Orthobion GmbH investigates and produces targeted biomaterials for use in implants designed for the treatment of spinal column defects. The surface structures of materials and how they affect the adhesion of bones to implant surfaces are key issues in the production of…

    https://www.gesundheitsindustrie-bw.de/en/article/news/orthobion-gmbh-biomaterials-for-spinal-implants
  • Article - 04/07/2011 Schematic with several layers of different colour and structure.

    Gingiva grown in Petri dishes

    We use teeth to break down food and gum disease is the major cause of tooth loss. Our teeth are firmly anchored in the jaw bone and surrounded and supported by the gum (gingiva), one of the five types of tissue that make up the human periodontium. A complex interplay of biomolecules maintains homoeostasis, i.e. the natural balance, in the gum tissue. A team of researchers led by Prof. Dr. Pascal Tomakidi from the Freiburg University Medical…

    https://www.gesundheitsindustrie-bw.de/en/article/news/gingiva-grown-in-petri-dishes
  • Article - 04/07/2011 Dr. Harald Stallforth, CEO Research & Development and Vice Chairman of the Aesculap AG management board

    The use of regenerative biomaterials is likely to grow

    Tuttlingen-based Aesculap AG is committed to using different materials including ceramics, titanium and high-performance polymers for the development and production of implants. The medical technology company has come up with a solution to prevent people from developing allergies against substances used in prostheses. Dr. Harald Stallforth, CEO Research & Development and Vice Chairman of the Aesculap AG management board talks with a BioLAGO…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-use-of-regenerative-biomaterials-is-likely-to-grow
  • Article - 04/07/2011 14640_de.jpg

    The adhesion of cells to the endothelium and to artificial surfaces

    Professor Stefan W. Schneider from the Mannheim Medical Faculty is investigating the function of the vascular endothelium and its interaction with blood and tumour cells using microfluidics methods that enable him to measure the adhesion of cells to the walls of blood vessels under physiological flow conditions. As part of an interdisciplinary project, he is investigating the characteristics of wafer-thin surfaces covered with living cells, which…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-adhesion-of-cells-to-the-endothelium-and-to-artificial-surfaces
  • Press release - 30/06/2011 14663_de.jpg

    Cancer treatments: New information from fission yeast

    When a cell divides the genetic information in the chromosomes must be passed on error-free to the daughter cells. Researchers at the Friedrich Miescher Laboratory in Tübingen are studying this process using fission yeast as a model organism. In cooperation with researchers at the University of Tübingen they succeeded in attributing additional tasks to the Aurora enzymes which were already recognized as important cellular tools for the reliable…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/cancer-treatments-new-information-from-fission-yeast
  • Press release - 28/06/2011

    Constitution of Health Axis Europe signed

    Health technology clusters in Cambridge (UK), Leuven (Belgium) and Heidelberg (Germany) agreed on the formation of the Health Axis Europe alliance to foster health innovation across Europe.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/constitution-of-health-axis-europe-signed
  • Press release - 28/06/2011

    Ulcerative colitis: Lipid Therapeutics announces start of Phase IIb clinical trial

    Lipid Therapeutics, a biotechnology company, announced today that it has initiated a Phase IIb clinical trial with its lead product LT-02 in patients with ulcerative colitis. Lipid Therapeutics received approval for this multi-center, international trial from the authorities in Germany and Lithuania and is awaiting approval in Romania. Patient enrollment has already started in Germany and Lithuania.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ulcerative-colitis-lipid-therapeutics-announces-start-of-phase-iib-clinical-trial

Page 61 / 119

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • 119
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search